Page last updated: 2024-11-02

pioglitazone and Lactic Acidosis

pioglitazone has been researched along with Lactic Acidosis in 3 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawamori, R2
Phillips, P1
Braddon, J1
Kanazawa, A1

Reviews

2 reviews available for pioglitazone and Lactic Acidosis

ArticleYear
Oral hypoglycaemics. When not to use what.
    Australian family physician, 2002, Volume: 31, Issue:7

    Topics: Acarbose; Acidosis, Lactic; Aged; Contraindications; Diabetes Mellitus, Type 2; Female; Glyburide; H

2002
[Adverse effects of insulin sensitisers and biguanides].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

    Topics: Acidosis, Lactic; Animals; Biguanides; Capillary Permeability; Chemical and Drug Induced Liver Injur

2007

Other Studies

1 other study available for pioglitazone and Lactic Acidosis

ArticleYear
[Biguanide, pioglitazone and alpha-glucosidase inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 6

    Topics: Acidosis, Lactic; Biguanides; Body Weight; Chemical and Drug Induced Liver Injury; Digestive System;

2012